Tetraspecific antibodies show increased cellular proliferation inhibition compared to bispecific HER1/IGF1R and cMet/HER3 antibodies in co-cultures of different NSCLC cell lines. This evidence concerns the gene ERBB3 and non-small cell lung carcinoma.